Skip to main content
Premium Trial:

Request an Annual Quote

Daniel Grosu

Daniel Grosu has joined Sequenom as senior vice president and chief medical officer. Most recently, he was at Illumina as VP of clinical development and medical affairs. He also was Illumina's first CMO. Grosu's prior experience includes stints at Siemens Medical Solutions, Bayer HealthCare Pharmaceuticals, and Johnson & Johnson. 

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.